Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis
We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC).
Gespeichert in:
| Autor*in: |
Billiet, Charlotte [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells - Han, Xiaobing ELSEVIER, 2021, journal of the European Society for Therapeutic Radiology and Oncology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:110 ; year:2014 ; number:1 ; pages:3-8 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.radonc.2013.08.011 |
|---|
| Katalog-ID: |
ELV039202100 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV039202100 | ||
| 003 | DE-627 | ||
| 005 | 20230624055303.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.radonc.2013.08.011 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014004000012.pica |
| 035 | |a (DE-627)ELV039202100 | ||
| 035 | |a (ELSEVIER)S0167-8140(13)00396-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 570 |a 540 |q VZ |
| 100 | 1 | |a Billiet, Charlotte |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis |
| 264 | 1 | |c 2014 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC). | ||
| 650 | 7 | |a Stage III |2 Elsevier | |
| 650 | 7 | |a Local tumor control |2 Elsevier | |
| 650 | 7 | |a PORT |2 Elsevier | |
| 650 | 7 | |a Non-small cell lung cancer |2 Elsevier | |
| 650 | 7 | |a Post-operative radiotherapy |2 Elsevier | |
| 650 | 7 | |a Survival |2 Elsevier | |
| 650 | 7 | |a Modeling |2 Elsevier | |
| 700 | 1 | |a Decaluwé, Herbert |4 oth | |
| 700 | 1 | |a Peeters, Stephanie |4 oth | |
| 700 | 1 | |a Vansteenkiste, Johan |4 oth | |
| 700 | 1 | |a Dooms, Christophe |4 oth | |
| 700 | 1 | |a Haustermans, Karin |4 oth | |
| 700 | 1 | |a De Leyn, Paul |4 oth | |
| 700 | 1 | |a De Ruysscher, Dirk |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Han, Xiaobing ELSEVIER |t Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |d 2021 |d journal of the European Society for Therapeutic Radiology and Oncology |g Amsterdam [u.a.] |w (DE-627)ELV00004122X |
| 773 | 1 | 8 | |g volume:110 |g year:2014 |g number:1 |g pages:3-8 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.radonc.2013.08.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 110 |j 2014 |e 1 |h 3-8 |g 6 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
c b cb |
|---|---|
| matchkey_str |
billietcharlottedecaluwherbertpeetersste:2014----:oenotprtvrdohrpfrtgiiosalelugacraipoeoac |
| hierarchy_sort_str |
2014 |
| publishDate |
2014 |
| allfields |
10.1016/j.radonc.2013.08.011 doi GBVA2014004000012.pica (DE-627)ELV039202100 (ELSEVIER)S0167-8140(13)00396-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Billiet, Charlotte verfasserin aut Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis 2014 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC). Stage III Elsevier Local tumor control Elsevier PORT Elsevier Non-small cell lung cancer Elsevier Post-operative radiotherapy Elsevier Survival Elsevier Modeling Elsevier Decaluwé, Herbert oth Peeters, Stephanie oth Vansteenkiste, Johan oth Dooms, Christophe oth Haustermans, Karin oth De Leyn, Paul oth De Ruysscher, Dirk oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:110 year:2014 number:1 pages:3-8 extent:6 https://doi.org/10.1016/j.radonc.2013.08.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 110 2014 1 3-8 6 045F 610 |
| spelling |
10.1016/j.radonc.2013.08.011 doi GBVA2014004000012.pica (DE-627)ELV039202100 (ELSEVIER)S0167-8140(13)00396-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Billiet, Charlotte verfasserin aut Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis 2014 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC). Stage III Elsevier Local tumor control Elsevier PORT Elsevier Non-small cell lung cancer Elsevier Post-operative radiotherapy Elsevier Survival Elsevier Modeling Elsevier Decaluwé, Herbert oth Peeters, Stephanie oth Vansteenkiste, Johan oth Dooms, Christophe oth Haustermans, Karin oth De Leyn, Paul oth De Ruysscher, Dirk oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:110 year:2014 number:1 pages:3-8 extent:6 https://doi.org/10.1016/j.radonc.2013.08.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 110 2014 1 3-8 6 045F 610 |
| allfields_unstemmed |
10.1016/j.radonc.2013.08.011 doi GBVA2014004000012.pica (DE-627)ELV039202100 (ELSEVIER)S0167-8140(13)00396-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Billiet, Charlotte verfasserin aut Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis 2014 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC). Stage III Elsevier Local tumor control Elsevier PORT Elsevier Non-small cell lung cancer Elsevier Post-operative radiotherapy Elsevier Survival Elsevier Modeling Elsevier Decaluwé, Herbert oth Peeters, Stephanie oth Vansteenkiste, Johan oth Dooms, Christophe oth Haustermans, Karin oth De Leyn, Paul oth De Ruysscher, Dirk oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:110 year:2014 number:1 pages:3-8 extent:6 https://doi.org/10.1016/j.radonc.2013.08.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 110 2014 1 3-8 6 045F 610 |
| allfieldsGer |
10.1016/j.radonc.2013.08.011 doi GBVA2014004000012.pica (DE-627)ELV039202100 (ELSEVIER)S0167-8140(13)00396-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Billiet, Charlotte verfasserin aut Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis 2014 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC). Stage III Elsevier Local tumor control Elsevier PORT Elsevier Non-small cell lung cancer Elsevier Post-operative radiotherapy Elsevier Survival Elsevier Modeling Elsevier Decaluwé, Herbert oth Peeters, Stephanie oth Vansteenkiste, Johan oth Dooms, Christophe oth Haustermans, Karin oth De Leyn, Paul oth De Ruysscher, Dirk oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:110 year:2014 number:1 pages:3-8 extent:6 https://doi.org/10.1016/j.radonc.2013.08.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 110 2014 1 3-8 6 045F 610 |
| allfieldsSound |
10.1016/j.radonc.2013.08.011 doi GBVA2014004000012.pica (DE-627)ELV039202100 (ELSEVIER)S0167-8140(13)00396-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Billiet, Charlotte verfasserin aut Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis 2014 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC). Stage III Elsevier Local tumor control Elsevier PORT Elsevier Non-small cell lung cancer Elsevier Post-operative radiotherapy Elsevier Survival Elsevier Modeling Elsevier Decaluwé, Herbert oth Peeters, Stephanie oth Vansteenkiste, Johan oth Dooms, Christophe oth Haustermans, Karin oth De Leyn, Paul oth De Ruysscher, Dirk oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:110 year:2014 number:1 pages:3-8 extent:6 https://doi.org/10.1016/j.radonc.2013.08.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 110 2014 1 3-8 6 045F 610 |
| language |
English |
| source |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:110 year:2014 number:1 pages:3-8 extent:6 |
| sourceStr |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:110 year:2014 number:1 pages:3-8 extent:6 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Stage III Local tumor control PORT Non-small cell lung cancer Post-operative radiotherapy Survival Modeling |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| authorswithroles_txt_mv |
Billiet, Charlotte @@aut@@ Decaluwé, Herbert @@oth@@ Peeters, Stephanie @@oth@@ Vansteenkiste, Johan @@oth@@ Dooms, Christophe @@oth@@ Haustermans, Karin @@oth@@ De Leyn, Paul @@oth@@ De Ruysscher, Dirk @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00004122X |
| dewey-sort |
3610 |
| id |
ELV039202100 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039202100</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624055303.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2013.08.011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014004000012.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039202100</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(13)00396-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Billiet, Charlotte</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC).</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stage III</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Local tumor control</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PORT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Non-small cell lung cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Post-operative radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Modeling</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Decaluwé, Herbert</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peeters, Stephanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vansteenkiste, Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dooms, Christophe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Haustermans, Karin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Leyn, Paul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Ruysscher, Dirk</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:110</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:3-8</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2013.08.011</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">110</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="h">3-8</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Billiet, Charlotte |
| spellingShingle |
Billiet, Charlotte ddc 610 ddc 570 Elsevier Stage III Elsevier Local tumor control Elsevier PORT Elsevier Non-small cell lung cancer Elsevier Post-operative radiotherapy Elsevier Survival Elsevier Modeling Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis |
| authorStr |
Billiet, Charlotte |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00004122X |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 570 540 VZ Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis Stage III Elsevier Local tumor control Elsevier PORT Elsevier Non-small cell lung cancer Elsevier Post-operative radiotherapy Elsevier Survival Elsevier Modeling Elsevier |
| topic |
ddc 610 ddc 570 Elsevier Stage III Elsevier Local tumor control Elsevier PORT Elsevier Non-small cell lung cancer Elsevier Post-operative radiotherapy Elsevier Survival Elsevier Modeling |
| topic_unstemmed |
ddc 610 ddc 570 Elsevier Stage III Elsevier Local tumor control Elsevier PORT Elsevier Non-small cell lung cancer Elsevier Post-operative radiotherapy Elsevier Survival Elsevier Modeling |
| topic_browse |
ddc 610 ddc 570 Elsevier Stage III Elsevier Local tumor control Elsevier PORT Elsevier Non-small cell lung cancer Elsevier Post-operative radiotherapy Elsevier Survival Elsevier Modeling |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
h d hd s p sp j v jv c d cd k h kh l p d lp lpd r d d rd rdd |
| hierarchy_parent_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| hierarchy_parent_id |
ELV00004122X |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00004122X |
| title |
Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis |
| ctrlnum |
(DE-627)ELV039202100 (ELSEVIER)S0167-8140(13)00396-4 |
| title_full |
Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis |
| author_sort |
Billiet, Charlotte |
| journal |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| journalStr |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
3 |
| author_browse |
Billiet, Charlotte |
| container_volume |
110 |
| physical |
6 |
| class |
610 610 DE-600 570 540 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Billiet, Charlotte |
| doi_str_mv |
10.1016/j.radonc.2013.08.011 |
| dewey-full |
610 570 540 |
| title_sort |
modern post-operative radiotherapy for stage iii non-small cell lung cancer may improve local control and survival: a meta-analysis |
| title_auth |
Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis |
| abstract |
We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC). |
| abstractGer |
We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC). |
| abstract_unstemmed |
We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC). |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis |
| url |
https://doi.org/10.1016/j.radonc.2013.08.011 |
| remote_bool |
true |
| author2 |
Decaluwé, Herbert Peeters, Stephanie Vansteenkiste, Johan Dooms, Christophe Haustermans, Karin De Leyn, Paul De Ruysscher, Dirk |
| author2Str |
Decaluwé, Herbert Peeters, Stephanie Vansteenkiste, Johan Dooms, Christophe Haustermans, Karin De Leyn, Paul De Ruysscher, Dirk |
| ppnlink |
ELV00004122X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.radonc.2013.08.011 |
| up_date |
2024-07-06T20:02:06.548Z |
| _version_ |
1803861231193292800 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039202100</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624055303.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2013.08.011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014004000012.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039202100</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(13)00396-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Billiet, Charlotte</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">We hypothesized that modern postoperative radiotherapy (PORT) could decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC).</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stage III</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Local tumor control</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PORT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Non-small cell lung cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Post-operative radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Modeling</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Decaluwé, Herbert</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peeters, Stephanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vansteenkiste, Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dooms, Christophe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Haustermans, Karin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Leyn, Paul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Ruysscher, Dirk</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:110</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:3-8</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2013.08.011</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">110</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="h">3-8</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400031 |